|
Re: Phase 3 - Fall Start
|
3
|
Resverlogix Corp.
|
Jun 22, 2015 02:14PM
|
|
Re: Phase 3 - Fall Start
|
5
|
Resverlogix Corp.
|
Jun 22, 2015 03:48PM
|
|
Re: Phase 2 Kidney Trial
|
4
|
Resverlogix Corp.
|
Jan 24, 2017 05:09PM
|
|
Re: Phase 1 Renal Trial Completed
|
4
|
Resverlogix Corp.
|
Sep 20, 2016 09:04AM
|
|
Re: Pfizer's PCSK9 Inhibitor bococizumab - further development being scrapped
|
4
|
Resverlogix Corp.
|
Nov 01, 2016 02:03PM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
4
|
Resverlogix Corp.
|
Jun 29, 2019 06:17PM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
4
|
Resverlogix Corp.
|
Jun 30, 2019 02:53PM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
7
|
Resverlogix Corp.
|
Jun 30, 2019 10:34PM
|
|
Re: Pfizer vs J&J - Nonmetastatic prostate cancer
|
5
|
Zenith Epigenetics
|
Feb 06, 2018 11:48AM
|
|
Re: Pfizer vs J&J - Nonmetastatic prostate cancer
|
5
|
Zenith Epigenetics
|
Feb 06, 2018 02:19PM
|
|
Re: Pfizer enzalutimide perspective
|
7
|
Zenith Epigenetics
|
May 16, 2017 10:49AM
|
|
Re: Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)
|
3
|
Zenith Epigenetics
|
Dec 14, 2016 05:36PM
|
|
Re: Pfizer /Astellas perfect affair ...
|
5
|
Resverlogix Corp.
|
Aug 23, 2016 03:10PM
|
|
Re: Peter Libby / You Tube Interview
|
8
|
Resverlogix Corp.
|
Aug 16, 2019 09:07AM
|
|
Re: Perspective on # MACE events and timeline to top-line
|
7
|
Resverlogix Corp.
|
Sep 01, 2018 01:07PM
|
|
Re: people whining about the whining
|
3
|
Resverlogix Corp.
|
Dec 23, 2020 04:09PM
|
|
Re: people whining about the whining
|
5
|
Resverlogix Corp.
|
Dec 23, 2020 04:19PM
|
|
Re: PCSK9 Inhibitors Improve Patient Outcomes, But Will That Convince Payers to Pay for Them?
|
3
|
Resverlogix Corp.
|
Apr 10, 2017 11:40AM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 10:04AM
|
|
Re: Patient Years & MACE rate Question
|
3
|
Resverlogix Corp.
|
Jul 11, 2019 10:23AM
|
